Want to see TSE:INNO full AI Analyst Report?
InnoCan Pharma (INNO) Financial Statements
23 Followers
InnoCan Pharma Financial Overview
InnoCan Pharma's market cap is currently $8.55M. The company's EPS TTM is $-0.21; its P/E ratio is -6.56; InnoCan Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Mar 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 26.61M | $ 29.44M | $ 13.66M | $ 2.56M | $ 196.00K |
| Gross Profit | $ 23.93M | $ 26.19M | $ 11.98M | $ 2.11M | $ 121.00K |
| Operating Income | $ -1.25M | $ -1.25M | $ 3.80M | $ -6.27M | $ -7.48M |
| EBITDA | $ 130.00K | $ 961.00K | $ -3.77M | $ -3.85M | $ -10.04M |
| Net Income | $ -1.12M | $ -1.83M | $ -4.70M | $ -3.89M | $ -10.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.69M | $ 5.01M | $ 3.88M | $ 4.95M | $ 11.05M |
| Total Assets | $ 10.52M | $ 9.26M | $ 6.94M | $ 6.98M | $ 12.57M |
| Total Debt | $ 930.00K | $ 10.00K | $ 33.00K | $ 34.00K | $ 1.00K |
| Net Debt | $ -5.76M | $ -5.00M | $ -3.85M | $ -4.91M | $ -11.05M |
| Total Liabilities | $ 2.29M | $ 2.24M | $ 2.55M | $ 751.00K | $ 3.56M |
| Stockholders' Equity | $ 5.60M | $ 5.17M | $ 4.10M | $ 6.39M | $ 9.05M |
| Cash Flow | |||||
| Free Cash Flow | $ 479.00K | $ -1.59M | $ -3.95M | $ -6.09M | $ -6.67M |
| Operating Cash Flow | $ 495.00K | $ -1.58M | $ -3.90M | $ -6.07M | $ -6.63M |
| Investing Cash Flow | $ -15.00K | $ 54.00K | $ -84.00K | $ -31.00K | $ -48.00K |
| Financing Cash Flow | $ 1.15M | $ 2.70M | $ 2.92M | $ 125.00K | $ 15.30M |
Currency in USD
